<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549818</url>
  </required_header>
  <id_info>
    <org_study_id>SECI2020</org_study_id>
    <nct_id>NCT04549818</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Sacral Neuromodulation for Pelvic Cancer Pain: A Preliminary Report</brief_title>
  <official_title>Does Sacral Neuromodulation Relieve Chronic Pelvic Cancer Pain, Compared With Medical Treatment?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      in this trial, we will test the analgesic efficacy of sacral neuromodulation for patients&#xD;
      with pelvic cancer, complaining of chronic pelvic pain in comparison to medical treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 10, 2020</start_date>
  <completion_date type="Anticipated">December 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of intensity of pain</measure>
    <time_frame>The outcome will be measured at day 15 postoperatively.</time_frame>
    <description>The intensity of pain measured by VAS pain score (visual analogue pain scale) where 0= no pain and 10=the maximum tolerated pain</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>sacral neuromodulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sacral neuromodulation group, will be treated with Stimulation of the sacral nerve roots by placement of a lead and generator, typically using an implanted InterStim® device that provides constant electrical stimulation to the S 2, 3 and 4 nerve roots, for 2-week trial stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>this group will be treated with sustained release morphine tablets for pain control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sacral neuromodulation</intervention_name>
    <description>Sacral neuromodulation group, N=22 will be treated with Stimulation of the sacral nerve roots by placement of a lead and generator, typically using an implanted InterStim® device that provides constant electrical stimulation to the S 2, 3 and 4 nerve roots, for 2-week trial stimulation</description>
    <arm_group_label>sacral neuromodulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age, 18-70&#xD;
&#xD;
          -  Pain localized to the pelvic and perineal region&#xD;
&#xD;
          -  The pain is due to pelvic cancer or chronic pelvic pain after pelvic surgery for&#xD;
             cancer&#xD;
&#xD;
          -  The intensity of pain assessed by VAS (visual analogue pain scale) &gt; 7&#xD;
&#xD;
          -  Importantly, the included participants should gain &gt; 50% reduction of their pain in&#xD;
             response to sacral roots block, S2,3 and 4 with bupivacaine 0.5%, 2 ml for each root&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Coagulopathy&#xD;
&#xD;
          -  Infection at site of maneuver&#xD;
&#xD;
          -  Abnormal Psychological behavior that interfere with integrity of obtained data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>August 31, 2020</study_first_submitted>
  <study_first_submitted_qc>September 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Diab Fuad Hetta</investigator_full_name>
    <investigator_title>anesthesia dep. south egypt cancer institute, El methaque st., assuit city, Egypt</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pelvic Neoplasms</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

